Tamara Do
About Tamara Do
Tamara Do serves as the Senior Director and Head of Alliance Management at Nektar Therapeutics, where she has worked since 2018. With a strong background in project management and public health, she has held various roles in the pharmaceutical industry, including positions at Amgen, Onyx Pharmaceuticals, and Biomarin Pharmaceutical Inc.
Current Role at Nektar Therapeutics
Tamara Do serves as the Senior Director, Head of Alliance Management at Nektar Therapeutics, a position she has held since 2018. In this role, she oversees the management of strategic alliances, enhancing the company's collaborative efforts within the biopharmaceutical industry. Her responsibilities include fostering partnerships and ensuring effective communication between stakeholders, which is crucial for the success of joint initiatives.
Previous Experience at Nektar Therapeutics
Prior to her current role, Tamara Do worked at Nektar Therapeutics as Senior Director, Program Management from 2016 to 2018. During her tenure, she contributed to various projects that aligned with the company's strategic goals. Her experience in program management provided her with the skills necessary to lead complex initiatives and coordinate cross-functional teams.
Professional Background in Pharmaceutical Industry
Tamara Do has extensive experience in the pharmaceutical sector, having held various positions that focus on project management and alliance management. She worked at Amgen as a Senior Regional Medical Liaison from 2002 to 2007 and later at Onyx Pharmaceuticals as Associate Director, Project Management from 2007 to 2014. Additionally, she served as Director, Development Sciences Project Management at Biomarin Pharmaceutical Inc. from 2014 to 2015.
Education and Expertise
Tamara Do's educational background includes a Doctor of Philosophy in Philosophy from Columbia University, where she studied from 1996 to 2001. She also holds a Master of Public Health from Columbia University, achieved in 1996, and a Bachelor of Science in Physiology and Neuroscience from UC San Diego, completed in 1994. This diverse educational foundation informs her approach to alliance management and enhances her expertise in the biopharmaceutical field.